To explore the mechanism by which insulin suppressed the progression of NASH and HCC in STAM mice, gene expression analyses were performed for steatosis and fibrosis in these mice at 9 weeks of age, following on from a previous study, which suggested that gene expression profiles in steatosis showed a wide divergence by the time HCC become evident16. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.